STAGE III DISTAL BILE DUCT CANCER AJCC V8
Clinical trials for STAGE III DISTAL BILE DUCT CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III DISTAL BILE DUCT CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III DISTAL BILE DUCT CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-phase study tests a new drug called BAY 1895344 combined with standard chemotherapy (cisplatin, with or without gemcitabine) in people with advanced solid tumors, especially bladder cancer. The main goals are to find the safest dose and understand side effects. About 7…
Matched conditions: STAGE III DISTAL BILE DUCT CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:10 UTC
-
Targeted combo shows promise for tough biliary cancers
Disease control OngoingThis study tests whether adding the targeted drug binimetinib to standard chemotherapy (FOLFOX) can shrink tumors or help people with advanced biliary tract cancers live longer. It is for patients whose cancers have specific MAPK gene changes and have already tried one prior trea…
Matched conditions: STAGE III DISTAL BILE DUCT CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:54 UTC